

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.85791131 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.85791131 |
| 3 | cellular response to interleukin-15 (GO:0071350) | 6.68014684 |
| 4 | response to interleukin-15 (GO:0070672) | 6.43322775 |
| 5 | negative T cell selection (GO:0043383) | 6.40025355 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.15988422 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.14119023 |
| 8 | negative thymic T cell selection (GO:0045060) | 6.01651420 |
| 9 | activated T cell proliferation (GO:0050798) | 5.88884419 |
| 10 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.80422927 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.73591182 |
| 12 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.62720265 |
| 13 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.62720265 |
| 14 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.56765709 |
| 15 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.51415846 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.49025535 |
| 17 | positive thymic T cell selection (GO:0045059) | 5.48665001 |
| 18 | positive T cell selection (GO:0043368) | 5.39422323 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.38113512 |
| 20 | thymic T cell selection (GO:0045061) | 5.08442688 |
| 21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.97080603 |
| 22 | cytidine deamination (GO:0009972) | 4.95443662 |
| 23 | cytidine metabolic process (GO:0046087) | 4.95443662 |
| 24 | cytidine catabolic process (GO:0006216) | 4.95443662 |
| 25 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.86631974 |
| 26 | regulation of gamma-delta T cell activation (GO:0046643) | 4.78890642 |
| 27 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.78780752 |
| 28 | T cell selection (GO:0045058) | 4.58113272 |
| 29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.48329897 |
| 30 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.45735761 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.43134488 |
| 32 | T cell migration (GO:0072678) | 4.37986369 |
| 33 | positive regulation of cell killing (GO:0031343) | 4.35918420 |
| 34 | DNA deamination (GO:0045006) | 4.35155787 |
| 35 | regulation of cell killing (GO:0031341) | 4.31289100 |
| 36 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.22339063 |
| 37 | positive regulation of granulocyte differentiation (GO:0030854) | 4.14857000 |
| 38 | regulation of regulatory T cell differentiation (GO:0045589) | 4.05929755 |
| 39 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.00215786 |
| 40 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.94100069 |
| 41 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.92437430 |
| 42 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.81107237 |
| 43 | mast cell activation (GO:0045576) | 3.78223016 |
| 44 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.74682008 |
| 45 | T cell receptor signaling pathway (GO:0050852) | 3.74446491 |
| 46 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.71206708 |
| 47 | negative regulation of T cell apoptotic process (GO:0070233) | 3.68713062 |
| 48 | interferon-gamma production (GO:0032609) | 3.68625099 |
| 49 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.67590268 |
| 50 | negative regulation of viral genome replication (GO:0045071) | 3.66722863 |
| 51 | leukocyte aggregation (GO:0070486) | 3.58683962 |
| 52 | tolerance induction (GO:0002507) | 3.56739954 |
| 53 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.50325729 |
| 54 | positive regulation of T cell cytokine production (GO:0002726) | 3.46998154 |
| 55 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.46736860 |
| 56 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.45121415 |
| 57 | regulation of T cell tolerance induction (GO:0002664) | 3.44166304 |
| 58 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.43709474 |
| 59 | mast cell activation involved in immune response (GO:0002279) | 3.43257510 |
| 60 | mast cell degranulation (GO:0043303) | 3.43257510 |
| 61 | dendritic cell chemotaxis (GO:0002407) | 3.43017193 |
| 62 | negative regulation of T cell mediated immunity (GO:0002710) | 3.41409710 |
| 63 | cellular defense response (GO:0006968) | 3.40564932 |
| 64 | positive regulation of tolerance induction (GO:0002645) | 3.40452722 |
| 65 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.38227989 |
| 66 | natural killer cell activation (GO:0030101) | 3.36102233 |
| 67 | alpha-beta T cell differentiation (GO:0046632) | 3.35618385 |
| 68 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.34796930 |
| 69 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.34576626 |
| 70 | T cell costimulation (GO:0031295) | 3.31230700 |
| 71 | positive regulation of T cell mediated immunity (GO:0002711) | 3.28348831 |
| 72 | lymphocyte costimulation (GO:0031294) | 3.27635195 |
| 73 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.25587824 |
| 74 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.24234526 |
| 75 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.21200838 |
| 76 | Peyers patch development (GO:0048541) | 3.21200838 |
| 77 | T-helper cell differentiation (GO:0042093) | 3.20834661 |
| 78 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.20834661 |
| 79 | regulation of B cell differentiation (GO:0045577) | 3.20151525 |
| 80 | T cell differentiation (GO:0030217) | 3.18831985 |
| 81 | type I interferon signaling pathway (GO:0060337) | 3.13983225 |
| 82 | cellular response to type I interferon (GO:0071357) | 3.13983225 |
| 83 | response to interferon-beta (GO:0035456) | 3.13120418 |
| 84 | positive regulation of macrophage differentiation (GO:0045651) | 3.11123749 |
| 85 | alpha-beta T cell activation (GO:0046631) | 3.10478343 |
| 86 | actin nucleation (GO:0045010) | 3.10302819 |
| 87 | dendritic cell migration (GO:0036336) | 3.10184551 |
| 88 | response to type I interferon (GO:0034340) | 3.09783561 |
| 89 | regulation of T cell mediated immunity (GO:0002709) | 3.08021861 |
| 90 | positive regulation of leukocyte mediated immunity (GO:0002705) | 3.07934979 |
| 91 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.05770113 |
| 92 | T cell differentiation involved in immune response (GO:0002292) | 3.05770113 |
| 93 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.05770113 |
| 94 | negative regulation of innate immune response (GO:0045824) | 3.04418055 |
| 95 | regulation of tolerance induction (GO:0002643) | 3.03668926 |
| 96 | positive regulation of translational initiation (GO:0045948) | 3.02476426 |
| 97 | B cell receptor signaling pathway (GO:0050853) | 2.98584441 |
| 98 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.98338686 |
| 99 | positive regulation of mRNA catabolic process (GO:0061014) | 2.98092727 |
| 100 | positive regulation of B cell differentiation (GO:0045579) | 2.96523206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.57949457 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.13538838 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.38950442 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.71235377 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.28365352 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.91197019 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.83118472 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.80478261 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.23995723 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.15493956 |
| 11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.09588100 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.99444168 |
| 13 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.85790512 |
| 14 | UTX_26944678_Chip-Seq_JUKART_Human | 2.81263630 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.76614843 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.75127298 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.69046682 |
| 18 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.53222225 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.52698121 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.35777426 |
| 21 | GATA3_26560356_Chip-Seq_TH2_Human | 2.35349927 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.19767891 |
| 23 | MAF_26560356_Chip-Seq_TH2_Human | 2.13229375 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.07395772 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00070734 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97751437 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.97743902 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.97333597 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.77163037 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 1.76413690 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.75824553 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.70286275 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69658384 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.67261148 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67046158 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66164873 |
| 37 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.63550802 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62512313 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.62420966 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.61272569 |
| 41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56240214 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54556995 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50976349 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46222438 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.44500986 |
| 46 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41714272 |
| 47 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.31536343 |
| 48 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.27083718 |
| 49 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.24441011 |
| 50 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.21979121 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21189043 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16893026 |
| 53 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16641517 |
| 54 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.16571579 |
| 55 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11879445 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11273086 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07673518 |
| 58 | GATA3_26560356_Chip-Seq_TH1_Human | 1.04970155 |
| 59 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.03878343 |
| 60 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02343692 |
| 61 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.02311554 |
| 62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99903516 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97689603 |
| 64 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97057234 |
| 65 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.96422501 |
| 66 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96271976 |
| 67 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95733639 |
| 68 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.95536052 |
| 69 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93892594 |
| 70 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.91570714 |
| 71 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.90957237 |
| 72 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90796799 |
| 73 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88968605 |
| 74 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.88916408 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87846024 |
| 76 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87765845 |
| 77 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87015025 |
| 78 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.87005699 |
| 79 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.86843066 |
| 80 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.86499530 |
| 81 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85868750 |
| 82 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.85527918 |
| 83 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85180192 |
| 84 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.84889772 |
| 85 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84773873 |
| 86 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.84113782 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83425235 |
| 88 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.81800018 |
| 89 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81076443 |
| 90 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79566086 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77619172 |
| 92 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76171730 |
| 93 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.75332969 |
| 94 | P300_27268052_Chip-Seq_Bcells_Human | 0.75193283 |
| 95 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.74646017 |
| 96 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.74163654 |
| 97 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73696427 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73373948 |
| 99 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73373100 |
| 100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72706926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.55202213 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.87338825 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.95510455 |
| 4 | MP0000685_abnormal_immune_system | 3.36805198 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.35764272 |
| 6 | MP0009785_altered_susceptibility_to | 3.32288395 |
| 7 | MP0001800_abnormal_humoral_immune | 3.27321900 |
| 8 | MP0003436_decreased_susceptibility_to | 3.23727117 |
| 9 | MP0003724_increased_susceptibility_to | 3.14136289 |
| 10 | MP0002723_abnormal_immune_serum | 2.97944376 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.89110981 |
| 12 | MP0005025_abnormal_response_to | 2.87939961 |
| 13 | MP0001819_abnormal_immune_cell | 2.84421957 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.74246390 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.66646765 |
| 16 | MP0001790_abnormal_immune_system | 2.65579670 |
| 17 | MP0005387_immune_system_phenotype | 2.65579670 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.58577250 |
| 19 | MP0002398_abnormal_bone_marrow | 2.46498286 |
| 20 | MP0002419_abnormal_innate_immunity | 2.43216480 |
| 21 | MP0000703_abnormal_thymus_morphology | 2.37789705 |
| 22 | MP0002405_respiratory_system_inflammati | 2.34530454 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.30660786 |
| 24 | MP0000716_abnormal_immune_system | 2.27177239 |
| 25 | MP0004381_abnormal_hair_follicle | 2.23533338 |
| 26 | MP0010155_abnormal_intestine_physiology | 2.10772831 |
| 27 | MP0002722_abnormal_immune_system | 2.04714040 |
| 28 | MP0004947_skin_inflammation | 2.03096280 |
| 29 | MP0000689_abnormal_spleen_morphology | 2.01084937 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.97341712 |
| 31 | MP0003866_abnormal_defecation | 1.97310264 |
| 32 | MP0002006_tumorigenesis | 1.96519003 |
| 33 | MP0006082_CNS_inflammation | 1.92425447 |
| 34 | MP0005075_abnormal_melanosome_morpholog | 1.86777986 |
| 35 | MP0002009_preneoplasia | 1.80648477 |
| 36 | MP0002429_abnormal_blood_cell | 1.77636268 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.71123741 |
| 38 | MP0002933_joint_inflammation | 1.47788983 |
| 39 | MP0002396_abnormal_hematopoietic_system | 1.47461283 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.46066597 |
| 41 | MP0000858_altered_metastatic_potential | 1.42614523 |
| 42 | MP0008469_abnormal_protein_level | 1.38804475 |
| 43 | MP0004130_abnormal_muscle_cell | 1.34886045 |
| 44 | MP0009764_decreased_sensitivity_to | 1.27432436 |
| 45 | MP0005310_abnormal_salivary_gland | 1.26923575 |
| 46 | MP0001873_stomach_inflammation | 1.23370948 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.22344111 |
| 48 | MP0001853_heart_inflammation | 1.19403978 |
| 49 | MP0008877_abnormal_DNA_methylation | 1.08714704 |
| 50 | MP0000015_abnormal_ear_pigmentation | 1.07069653 |
| 51 | MP0001986_abnormal_taste_sensitivity | 1.02724924 |
| 52 | MP0009763_increased_sensitivity_to | 0.99934489 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 0.99733270 |
| 54 | MP0001851_eye_inflammation | 0.96238465 |
| 55 | MP0005174_abnormal_tail_pigmentation | 0.92487062 |
| 56 | MP0003787_abnormal_imprinting | 0.91040705 |
| 57 | MP0005377_hearing/vestibular/ear_phenot | 0.88349683 |
| 58 | MP0003878_abnormal_ear_physiology | 0.88349683 |
| 59 | MP0002163_abnormal_gland_morphology | 0.86645647 |
| 60 | MP0006072_abnormal_retinal_apoptosis | 0.83957999 |
| 61 | MP0002019_abnormal_tumor_incidence | 0.83255687 |
| 62 | MP0001348_abnormal_lacrimal_gland | 0.81990506 |
| 63 | MP0003448_altered_tumor_morphology | 0.80348447 |
| 64 | MP0001919_abnormal_reproductive_system | 0.80192059 |
| 65 | MP0000372_irregular_coat_pigmentation | 0.79272448 |
| 66 | MP0002998_abnormal_bone_remodeling | 0.73195935 |
| 67 | MP0000490_abnormal_crypts_of | 0.73084417 |
| 68 | MP0005451_abnormal_body_composition | 0.71418551 |
| 69 | MP0000569_abnormal_digit_pigmentation | 0.68814720 |
| 70 | MP0003252_abnormal_bile_duct | 0.68607350 |
| 71 | MP0002693_abnormal_pancreas_physiology | 0.66448132 |
| 72 | MP0001765_abnormal_ion_homeostasis | 0.65250978 |
| 73 | MP0004742_abnormal_vestibular_system | 0.61445940 |
| 74 | MP0009765_abnormal_xenobiotic_induced | 0.61314990 |
| 75 | MP0003828_pulmonary_edema | 0.61288167 |
| 76 | MP0003045_fibrosis | 0.60847244 |
| 77 | MP0002638_abnormal_pupillary_reflex | 0.58624521 |
| 78 | MP0002132_abnormal_respiratory_system | 0.56774843 |
| 79 | MP0005390_skeleton_phenotype | 0.56686760 |
| 80 | MP0005166_decreased_susceptibility_to | 0.56338518 |
| 81 | MP0003303_peritoneal_inflammation | 0.55229926 |
| 82 | MP0001243_abnormal_dermal_layer | 0.49957289 |
| 83 | MP0008961_abnormal_basal_metabolism | 0.48679170 |
| 84 | MP0003172_abnormal_lysosome_physiology | 0.47612404 |
| 85 | MP0008873_increased_physiological_sensi | 0.47241192 |
| 86 | MP0004264_abnormal_extraembryonic_tissu | 0.47213654 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.46595509 |
| 88 | MP0004134_abnormal_chest_morphology | 0.46271761 |
| 89 | MP0004885_abnormal_endolymph | 0.46252177 |
| 90 | MP0003638_abnormal_response/metabolism_ | 0.45819550 |
| 91 | MP0008057_abnormal_DNA_replication | 0.45190342 |
| 92 | MP0000249_abnormal_blood_vessel | 0.44652041 |
| 93 | MP0002138_abnormal_hepatobiliary_system | 0.42791419 |
| 94 | MP0003786_premature_aging | 0.42711184 |
| 95 | MP0004185_abnormal_adipocyte_glucose | 0.41821211 |
| 96 | MP0002095_abnormal_skin_pigmentation | 0.40120102 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.40016562 |
| 98 | MP0000609_abnormal_liver_physiology | 0.38904553 |
| 99 | MP0009642_abnormal_blood_homeostasis | 0.38791684 |
| 100 | MP0000477_abnormal_intestine_morphology | 0.38644290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.71257797 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.67180726 |
| 3 | IgG deficiency (HP:0004315) | 6.13950511 |
| 4 | Increased IgM level (HP:0003496) | 6.09471203 |
| 5 | Myositis (HP:0100614) | 4.95417901 |
| 6 | Abnormality of T cells (HP:0002843) | 4.88493618 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.85902344 |
| 8 | Optic neuritis (HP:0100653) | 4.85902344 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.82928289 |
| 10 | Severe combined immunodeficiency (HP:0004430) | 4.81966494 |
| 11 | Abnormality of eosinophils (HP:0001879) | 4.62181407 |
| 12 | Eosinophilia (HP:0001880) | 4.54063022 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.47724756 |
| 14 | Orchitis (HP:0100796) | 4.39608256 |
| 15 | Granulocytopenia (HP:0001913) | 4.35044572 |
| 16 | Encephalitis (HP:0002383) | 4.30905187 |
| 17 | Autoimmune hemolytic anemia (HP:0001890) | 4.14963109 |
| 18 | Stomatitis (HP:0010280) | 4.12620756 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.90722717 |
| 20 | Leukocytosis (HP:0001974) | 3.86047143 |
| 21 | Abnormality of B cell number (HP:0010975) | 3.81640982 |
| 22 | Combined immunodeficiency (HP:0005387) | 3.80050084 |
| 23 | Meningitis (HP:0001287) | 3.72010692 |
| 24 | Vasculitis (HP:0002633) | 3.70524939 |
| 25 | Joint swelling (HP:0001386) | 3.66673687 |
| 26 | Pustule (HP:0200039) | 3.62457805 |
| 27 | Eczematoid dermatitis (HP:0000976) | 3.60264957 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 3.58157351 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 3.57284181 |
| 30 | Abnormality of T cell physiology (HP:0011840) | 3.52366322 |
| 31 | Hypoproteinemia (HP:0003075) | 3.49383110 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.46797392 |
| 33 | Recurrent cutaneous fungal infections (HP:0011370) | 3.46797392 |
| 34 | Pulmonary infiltrates (HP:0002113) | 3.45910045 |
| 35 | Chronic diarrhea (HP:0002028) | 3.39487872 |
| 36 | Keratoconjunctivitis sicca (HP:0001097) | 3.37263496 |
| 37 | Keratoconjunctivitis (HP:0001096) | 3.29921969 |
| 38 | Hypergammaglobulinemia (HP:0010702) | 3.26997637 |
| 39 | Recurrent viral infections (HP:0004429) | 3.26526960 |
| 40 | Thyroiditis (HP:0100646) | 3.24679891 |
| 41 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.15749853 |
| 42 | Hemoptysis (HP:0002105) | 3.15508017 |
| 43 | Recurrent bronchitis (HP:0002837) | 3.14067756 |
| 44 | Lymphopenia (HP:0001888) | 3.11522497 |
| 45 | B lymphocytopenia (HP:0010976) | 3.08292904 |
| 46 | Hypoplasia of the thymus (HP:0000778) | 2.86879989 |
| 47 | Agammaglobulinemia (HP:0004432) | 2.86254287 |
| 48 | Gastrointestinal infarctions (HP:0005244) | 2.76300700 |
| 49 | Stomach cancer (HP:0012126) | 2.76232128 |
| 50 | Recurrent bacterial skin infections (HP:0005406) | 2.75294487 |
| 51 | Mediastinal lymphadenopathy (HP:0100721) | 2.71649843 |
| 52 | IgM deficiency (HP:0002850) | 2.71053514 |
| 53 | Gangrene (HP:0100758) | 2.67125027 |
| 54 | Arterial thrombosis (HP:0004420) | 2.66820821 |
| 55 | Recurrent abscess formation (HP:0002722) | 2.66106660 |
| 56 | Increased IgE level (HP:0003212) | 2.56153989 |
| 57 | Recurrent skin infections (HP:0001581) | 2.53146462 |
| 58 | Abnormality of the pleura (HP:0002103) | 2.45833477 |
| 59 | Lymphoma (HP:0002665) | 2.44267918 |
| 60 | Hemiplegia (HP:0002301) | 2.44029647 |
| 61 | Obstructive lung disease (HP:0006536) | 2.43051664 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.43051664 |
| 63 | IgA deficiency (HP:0002720) | 2.42752964 |
| 64 | Pulmonary embolism (HP:0002204) | 2.40643497 |
| 65 | Abnormality of macrophages (HP:0004311) | 2.37177496 |
| 66 | Keratitis (HP:0000491) | 2.36690379 |
| 67 | Spontaneous hematomas (HP:0007420) | 2.36164335 |
| 68 | Anorexia (HP:0002039) | 2.34889026 |
| 69 | Chest pain (HP:0100749) | 2.34298807 |
| 70 | Abnormality of the prostate (HP:0008775) | 2.30600197 |
| 71 | Glomerulopathy (HP:0100820) | 2.30294250 |
| 72 | Acute hepatic failure (HP:0006554) | 2.28840360 |
| 73 | Verrucae (HP:0200043) | 2.25286415 |
| 74 | Papilloma (HP:0012740) | 2.25286415 |
| 75 | Hypochromic anemia (HP:0001931) | 2.22899711 |
| 76 | Prolonged bleeding time (HP:0003010) | 2.14719238 |
| 77 | Polyneuropathy (HP:0001271) | 2.10272209 |
| 78 | Bronchitis (HP:0012387) | 2.02484485 |
| 79 | Inflammation of the large intestine (HP:0002037) | 1.95195998 |
| 80 | Epistaxis (HP:0000421) | 1.94456709 |
| 81 | Gingival bleeding (HP:0000225) | 1.90948019 |
| 82 | Pulmonary fibrosis (HP:0002206) | 1.90872205 |
| 83 | Abnormality of the endocardium (HP:0004306) | 1.89542484 |
| 84 | Neutropenia (HP:0001875) | 1.86729080 |
| 85 | Vertigo (HP:0002321) | 1.85422416 |
| 86 | Increased serum ferritin (HP:0003281) | 1.84949684 |
| 87 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.82535344 |
| 88 | Gastrointestinal inflammation (HP:0004386) | 1.81171772 |
| 89 | Papilledema (HP:0001085) | 1.76001051 |
| 90 | Skin rash (HP:0000988) | 1.74952777 |
| 91 | Fatigue (HP:0012378) | 1.73821069 |
| 92 | 3-Methylglutaconic aciduria (HP:0003535) | 1.68735911 |
| 93 | Arthralgia (HP:0002829) | 1.67968401 |
| 94 | Urticaria (HP:0001025) | 1.67701265 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 1.65400229 |
| 96 | Gastrointestinal stroma tumor (HP:0100723) | 1.64521161 |
| 97 | Acne (HP:0001061) | 1.62418962 |
| 98 | Anhidrosis (HP:0000970) | 1.61631401 |
| 99 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.59338073 |
| 100 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.56951229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 5.86270075 |
| 2 | TXK | 5.51073931 |
| 3 | MAP4K1 | 3.96131016 |
| 4 | GRK6 | 3.37761653 |
| 5 | MAP3K14 | 2.77684365 |
| 6 | FES | 2.71544041 |
| 7 | TESK2 | 2.41376708 |
| 8 | KDR | 2.22288576 |
| 9 | TNK2 | 2.17141123 |
| 10 | JAK1 | 2.08700683 |
| 11 | TLK1 | 2.07530494 |
| 12 | ZAP70 | 2.01824630 |
| 13 | ITK | 1.95729839 |
| 14 | ZAK | 1.94264482 |
| 15 | CSK | 1.91982254 |
| 16 | PRPF4B | 1.87772995 |
| 17 | JAK3 | 1.83872288 |
| 18 | IKBKE | 1.80946125 |
| 19 | VRK1 | 1.80810607 |
| 20 | BTK | 1.77613741 |
| 21 | RIPK1 | 1.68615057 |
| 22 | SYK | 1.65136956 |
| 23 | TBK1 | 1.63320494 |
| 24 | LCK | 1.52609849 |
| 25 | MAP2K2 | 1.52322011 |
| 26 | TYK2 | 1.45702587 |
| 27 | RIPK4 | 1.45621492 |
| 28 | MST4 | 1.44402580 |
| 29 | TYRO3 | 1.42256160 |
| 30 | SIK2 | 1.31854770 |
| 31 | SIK3 | 1.31050942 |
| 32 | MAP2K6 | 1.28302043 |
| 33 | PRKCQ | 1.25452136 |
| 34 | TRIM28 | 1.25383690 |
| 35 | LYN | 1.21518908 |
| 36 | TEC | 1.15386127 |
| 37 | IRAK3 | 1.14652873 |
| 38 | NLK | 1.14216688 |
| 39 | IKBKB | 1.11426403 |
| 40 | HCK | 1.09185289 |
| 41 | BLK | 1.01694132 |
| 42 | NUAK1 | 1.00909013 |
| 43 | TRPM7 | 0.99914345 |
| 44 | ADRBK2 | 0.97457689 |
| 45 | CAMKK1 | 0.95691927 |
| 46 | CAMKK2 | 0.90505804 |
| 47 | PIM1 | 0.89480878 |
| 48 | STK10 | 0.86259058 |
| 49 | BCKDK | 0.85203981 |
| 50 | MAPK7 | 0.84711478 |
| 51 | KIT | 0.83856028 |
| 52 | MAP3K12 | 0.83086946 |
| 53 | MAPK11 | 0.81368568 |
| 54 | PIK3CA | 0.80158582 |
| 55 | PIK3CG | 0.80028901 |
| 56 | FGFR4 | 0.79919279 |
| 57 | MAP3K13 | 0.72854907 |
| 58 | CDK4 | 0.71657708 |
| 59 | GRK7 | 0.70002963 |
| 60 | TGFBR2 | 0.68538259 |
| 61 | BRD4 | 0.67992393 |
| 62 | IRAK4 | 0.67210836 |
| 63 | CLK1 | 0.65415269 |
| 64 | JAK2 | 0.62645716 |
| 65 | MATK | 0.56236408 |
| 66 | FGFR3 | 0.54206381 |
| 67 | PDGFRB | 0.53284261 |
| 68 | PDK1 | 0.51060140 |
| 69 | CDK8 | 0.49818398 |
| 70 | MARK3 | 0.46283235 |
| 71 | FYN | 0.46172394 |
| 72 | CSF1R | 0.44980987 |
| 73 | BCR | 0.44329261 |
| 74 | BMPR2 | 0.42552963 |
| 75 | MAPKAPK2 | 0.42260937 |
| 76 | MAP3K11 | 0.40890594 |
| 77 | MAPK12 | 0.39660158 |
| 78 | IGF1R | 0.39511262 |
| 79 | HIPK2 | 0.37177498 |
| 80 | INSR | 0.31061021 |
| 81 | LRRK2 | 0.24864700 |
| 82 | EIF2AK2 | 0.23407528 |
| 83 | MAPK3 | 0.23293656 |
| 84 | MAP3K10 | 0.22787373 |
| 85 | MAP3K1 | 0.21376868 |
| 86 | ACVR1B | 0.21266332 |
| 87 | NTRK2 | 0.18549772 |
| 88 | CHUK | 0.18385550 |
| 89 | BUB1 | 0.17719917 |
| 90 | MELK | 0.17708978 |
| 91 | RPS6KA5 | 0.17423070 |
| 92 | MAP4K2 | 0.17409645 |
| 93 | RET | 0.17035898 |
| 94 | TESK1 | 0.15431219 |
| 95 | WNK4 | 0.15308520 |
| 96 | EGFR | 0.14738574 |
| 97 | FGR | 0.14296497 |
| 98 | CDK6 | 0.13921316 |
| 99 | PRKCH | 0.13046378 |
| 100 | NEK6 | 0.12282556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.48236898 |
| 2 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.10444486 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.83381202 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.47558409 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.04227958 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.88505876 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.79632946 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.78626357 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.53888353 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.38989969 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.35631392 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.16778754 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.13684182 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.03221660 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.84526296 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.82966609 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.79231813 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.73426716 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.73358197 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.66096402 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.65764285 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.59835056 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.59531993 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.58686018 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.52071821 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39965671 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38280016 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.37067152 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36909245 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.35377682 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.34942159 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.30980241 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.25040805 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23508276 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17610110 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.11097117 |
| 37 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.04458562 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 0.99868804 |
| 39 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92788440 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 0.86115544 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86038239 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85965249 |
| 43 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85502263 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 0.84930387 |
| 45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82591286 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 0.78041923 |
| 47 | Proteasome_Homo sapiens_hsa03050 | 0.76827606 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75637647 |
| 49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68724409 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66261578 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65197575 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.64176342 |
| 53 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63485146 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 0.61863822 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 0.58998124 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.58365394 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56724969 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55749344 |
| 59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49129221 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44816975 |
| 61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43308486 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41356078 |
| 63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40740317 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40269702 |
| 65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.38361808 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37962579 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.36825589 |
| 68 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.34193866 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.33286477 |
| 70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32400462 |
| 71 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31908591 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28777568 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.28675184 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27329828 |
| 75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26542270 |
| 76 | RNA polymerase_Homo sapiens_hsa03020 | 0.26505566 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.26089989 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25403267 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25385441 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24131723 |
| 81 | Prostate cancer_Homo sapiens_hsa05215 | 0.23810770 |
| 82 | Homologous recombination_Homo sapiens_hsa03440 | 0.23321524 |
| 83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.22477268 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22211870 |
| 85 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.19582408 |
| 86 | Basal transcription factors_Homo sapiens_hsa03022 | 0.16928453 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16476764 |
| 88 | Phototransduction_Homo sapiens_hsa04744 | 0.15369401 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.13676766 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.12778761 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.12531013 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.10346969 |
| 93 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.09113432 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.08876096 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.08545926 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.08459923 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.07394809 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.07176152 |
| 99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.06781304 |
| 100 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.06747527 |

